AGP Executive Report
Last update: 8 hours agoHealthcare & Tech: A new non-invasive glucose monitor, GLUCUBE, has received EU medical device CE marking, aiming to help type 2 diabetics track levels without finger pricks. Public Health Regulation: Spain’s family and community doctors’ group semFYC is urging more preventive rules on endocrine disruptors, stressing exposure timing during fetal development, childhood and puberty. Business & Regional Trade: Demerara Distillers Limited (DDL) is expanding in St Kitts and Nevis with a US$10m project to add bottling and use the island as a hub for Guyanese-made drinks across smaller Caribbean markets. Diaspora Investment: A Montserrat-led healthcare proposal is targeting US$6m for Phase One, with mobile units and lab services, and hopes to start implementation as early as Feb 2027. EU Oversight: An EU Parliament delegation says Greece has improved rail safety after the 2023 Tempi disaster, but warns reforms are moving too slowly and key safety systems aren’t fully deployed. Travel & Consumer Costs: A winter-sun cost barometer highlights Cape Town as top value, while a guide for Bangladeshi passport holders notes “visa-free” access can change and may include conditions like VOA or ETAs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
